Tijet Nathalie, Faccone Diego, Rapoport Melina, Seah Christine, Pasterán Fernando, Ceriana Paola, Albornoz Ezequiel, Corso Alejandra, Petroni Alejandro, Melano Roberto G
Public Health Ontario Laboratory, Toronto, Ontario, Canada.
Servicio Antimicrobianos, National and Regional Reference Laboratory in Antimicrobial Resistance, Instituto Nacional de Enfermedades Infecciosas (INEI)-ANLIS "Dr. C. Malbran", Buenos Aires, Argentina.
PLoS One. 2017 Jul 5;12(7):e0180347. doi: 10.1371/journal.pone.0180347. eCollection 2017.
We have characterized nine mcr-1-harboring plasmids from clinical Escherichia coli isolates previously described in Argentina and Canada. Three of these plasmids carried a mcr-1-variant called here mcr-1.5. All these E. coli isolates were not clonally related and were recovered in different years and locations. However, their mcr-1-harboring plasmids showed high identity among them and to others characterized in other countries, which strongly suggests that this plasmid-type is playing an important role in spreading this mechanism of resistance to polymyxins.
我们对先前在阿根廷和加拿大描述的临床大肠杆菌分离株中携带mcr-1的9种质粒进行了特征分析。其中3种质粒携带一种mcr-1变体,我们在此将其称为mcr-1.5。所有这些大肠杆菌分离株并无克隆相关性,且是在不同年份和地点分离得到的。然而,它们携带mcr-1的质粒相互之间以及与其他国家鉴定的质粒具有高度同一性,这有力地表明这种质粒类型在传播这种对多粘菌素的耐药机制中发挥着重要作用。